Plant-Produced Monoclonal Antibody as Immunotherapy for Cancer

Figure 1

Clinical phases for antibody therapeutics in development. Totals include only antibody therapeutics (biosimilars and Fc fusion proteins were excluded) sponsored by commercial firms [14].